A step forward for two-step screening for ovarian cancer.
Hensley
Martee L
ML
D014408:Biomarkers, Tumor / Q000097:blood*; D018394:CA-125 Antigen / Q000097:blood; D002272:Carcinoembryonic Antigen / Q000097:blood; D055088:Early Detection of Cancer; D030501:Epididymal Secretory Proteins / Q000032:analysis; D005260:Female; D006801:Humans; D007118:Immunoassay; D008403:Mass Screening / Q000379:methods*; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000473:pathology; D011237:Predictive Value of Tests; D011379:Prognosis; D012680:Sensitivity and Specificity; D019010:Vascular Cell Adhesion Molecule-1 / Q000097:blood; D023083:beta-Defensins
D014408:Biomarkers, Tumor; D018394:CA-125 Antigen; D002272:Carcinoembryonic Antigen; C426184:DEFB126 protein, human; D030501:Epididymal Secretory Proteins; D019010:Vascular Cell Adhesion Molecule-1; D023083:beta-Defensins